Navigation Links
Key player found for a cancer typical in Down syndrome
Date:3/1/2010

Boston, Mass. Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets. Now, researchers at Children's Hospital Boston have found a gene regulator they believe to be a key player in DS-AMKL, advancing understanding of how the disease develops and how to treat it.

The study findings, published in the March 1 issue of Genes and Development, may also help in understanding other forms of leukemia, the researchers say.

The gene regulator, miR-125b-2, belongs to a class of molecules known as microRNAs, which silence gene expression by halting the manufacturing of different proteins. While microRNAs are important to normal cell function, unusual amounts of them can lead to disease. "DS-AMKL has a very strong genetic basis," says senior investigator Stuart Orkin, MD, of the Division of Hematology/Oncology at Children's. "However, there aren't that many cancers in which a particular microRNA can be pointed to as contributing."

Because children with Down syndrome have three copies of chromosome 21 rather than the usual two copies, the researchers focused on the five microRNAs produced by this chromosome, and zeroed in on miR-125b-2.

"In human primary DS-AMKL cells, this microRNA is quite dramatically over-expressed," says Zhe Li, PhD, of Children's Division of Hematology/Oncology and first author of the paper. "We then went back and studied how over-expression or downregulation of this microRNA affects the phenotype of leukemia cells."

DS-AMKL is always associated with mutations in the gene GATA1, which helps make and regulate red blood cells and megakaryocytes (the cells that produce platelets
'/>"/>

Contact: Rob Graham
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Little-known protein found to be key player
2. New study finds lowfat chocolate milk is effective post-exercise recovery aid for soccer players
3. New estrogen receptor found to be key player in tamoxifen resistance
4. Frost & Sullivan Recognizes Precise Biometrics as a Key Player in the Non-AFIS Fingerprint Market
5. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
6. Black carbon pollution emerges as major player in global warming
7. Scientists discover a new player in innate immune response
8. Rockefeller Foundation supports expansion, training of e-health work force in developing world
9. Lymphoma Research Foundation announces publication of Mantle Cell report
10. Anorexics found to have excess fat-- in their bone marrow
11. Scripps Research scientists find two compounds that lay the foundation for a new class of AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 Cryoport, Inc. (OTCBB: ... cryogenic logistics solutions for the life sciences ... cell lines, clinical research organizations, vaccine manufacturers, ... the expansion of its relationship with ... Hutch") Clinical Research Division with the inclusion ...
(Date:3/2/2015)... , March 2, 2015  Businesses have a ... protection company Tharon Rankins Enterprises has announced the ... an ultra-safe way for businesses to protect their ... transactions. Beconux is a biometric ... Enterprises. Functioning similarly to an ATM machine, the ...
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial ... billing in the Health and Fitness Industry, today ... as to MYiCLUBonline.  The latest upgrade includes advances ... inclusion of cardless check-in via Identity One fingerprint ... first time through interactive displays at the International ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
... the European Society for Clinical and Economic Aspects of ... international congress devoted to musculoskeletal research and clinical practice ... Key facts about the IOF-ESCEO World Congress on Osteoporosis, ... More than 5000 delegates from 100 countries and over ...
... University of Minnesota College of Veterinary Medicine (CVM) has ... asthma. ORMDL3, a gene recently linked to asthma susceptibility, ... recruit inflammatory cells during an airway allergic reaction. Study ... . U of M researchers including Srirama Rao, ...
... 2013 EcoHealth Alliance, a nonprofit organization that focuses on ... a three-year, $2 million award to address land use alteration ... change in Asia. The funding for the new program ... Mission for Asia (RDMA). Over 60 percent of emerging ...
Cached Biology News:World's largest event for bone, muscle, and joint research and practice to be held in Spain 2U of M research uncovers gene's contribution to asthma susceptibility 2EcoHealth Alliance announces new award from USAID to combat disease emergence and climate change 2
(Date:3/4/2015)... 4, 2015   ... Diagnostik und Therapie, Strahlendosismanagement und IT-Lösungen für die ... Royal Philips (NYSE: PHG, AEX: PHIA) gab ... (ECR) bekannt, der vom 4. bis 8. März in ... Ständen Nr. 102 and 110 wird ...
(Date:3/3/2015)... 2015 NASA astronaut Scott Kelly , who ... spend a year living and working on the International Space ... to 7 a.m. EDT Monday, March 9. Kelly ... completes the final weeks of his training. The interviews will ... Television highlighting his mission training and previous spaceflights. ...
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ) has ... 2015 - 2025" report to their offering. ... an extensive study on the marketed and pipeline gene ... in this field for over a decade but there ... markets; one approved in the EU). There are many ...
(Date:3/3/2015)... March 3, 2015 Adaptive Biotechnologies announced today ... joining its Board of Director as Chair of the ... Zillow Group, Chad oversees all finance, treasury and accounting ... company,s core finance, treasury and accounting functions, and led ... acquisitions. In 2013, he was named Puget Sound Business ...
Breaking Biology Technology:Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX) ("GeoVax" or ... diseases caused by HIV-1 (Human,Immunodeficiency Virus) and other ... results and provided an operational update., Robert ... very,pleased with the progress we,ve made during the ...
... results in,more favorable lipid profile in mixed ... Using the VAP Cholesterol,Test from Atherotech, ... of,Point Medical, Rond Point de la Nation, ... subclasses and LDL particle size using,combination therapy. ...
... November 10 In a,presentation yesterday at ... from deCODE genetics (Nasdaq: DCGN ) presented ... populations that,underscore the clinical utility of the ... treatment of atrial fibrillation as a means ...
Cached Biology Technology:GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 2GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 3GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 4GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 5GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 6GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 7GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 8GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update 9VAP(R) Cholesterol Test Helps Researchers Identify Treatment Effects of Combination Therapy 2VAP(R) Cholesterol Test Helps Researchers Identify Treatment Effects of Combination Therapy 3deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke 2deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke 3deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke 4deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke 5
Acid phosphatase (Potato). Monospecific by IEP. Some cross reactivity between Acid phosphatases of other species may occur....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... Yersinia pestis This antibody is ... Immunogen: Purified F1 ... vaccine strain EV76. Specificity: ... capsular antigen. There is no cross-reactivity ...
Phospho-SEK1/MKK4 (Thr261) Antibody...
Biology Products: